Earnings Call · Q1 FY2024·2024-04-24

Q1 24EPS +7.14%·Rev n/aQ4 23EPS 0.00%·Rev n/aQ3 23EPS -4.55%·Rev n/aQ2 23EPS +5.00%·Rev n/a⚠ consensus missing

Viking Therapeutics, Inc. VKTX

Stephanie Diaz — Manager of Investor Relations

Brian Lian — President and Chief Executive Officer

Gregory Zante — Chief Financial Officer

+0.2%1d on move date+0.3% vs SPY3d+14.4%5d+22.6%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more VKTX calls or request research access.

More VKTX calls Browse calls Request research access